Trade

with

Data not available

Open

-

Previous Close

-

Volume (Avg)

-

Day's Range

-

52Wk Range

-

Market Cap.

-

P/E Ratio (EPS

-

Dividend Rate ( Yield )

-

Beta

0.90

Shares Outstanding

1.95M

P/E Ratio (EPS)

- (13.76)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
37.94M
Operating Margin
28.75
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Ownership

Institutional Ownership

50.44%

Top 10 Institutions

38.99%

Mutual Fund Ownership

35.60%

Float

55.62%

5% / Insider Ownership

12.29%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • T. Rowe Price Small Cap Value Fund

  •  

    171,700

  • -0.35

  • 8.81

  • Royce Special Equity Fund

  •  

    145,000

  • 0.00

  • 7.44

  • Columbia Small Cap Core Fund

  •  

    34,648

  • 0.00

  • 1.78

  • Vanguard Total Stock Mkt Idx

  •  

    28,394

  • 11.38

  • 1.46

  • iShares Russell 2000 (AU)

  •  

    23,102

  • -1.39

  • 1.20

  • DFA U.S. Micro Cap Portfolio

  •  

    19,961

  • 0.00

  • 1.02

  • Royce Value Trust

  •  

    19,054

  • 17.36

  • 0.98

  • Royce Micro-Cap Trust

  •  

    13,497

  • 8.00

  • 0.69

  • Royce Dividend Value Fund

  •  

    13,200

  • 0.00

  • 0.68

  • Vanguard Extended Market Index Fund

  •  

    12,369

  • 3.51

  • 0.63

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Royce & Associates, LLC

  •  

    218,994

  • -4.06%

  • 11.24

  • T. Rowe Price Associates, Inc.

  •  

    206,195

  • +2.30%

  • 10.58

  • Columbia Mangmt Investment Advisers, LLC

  •  

    60,377

  • -0.34%

  • 3.10

  • Wellington Management Company, LLP

  •  

    57,365

  • +20.88%

  • 2.94

  • Dimensional Fund Advisors, Inc.

  •  

    55,829

  • +0.53%

  • 2.86

  • BlackRock Fund Advisors

  •  

    50,082

  • +0.78%

  • 2.57

  • Vanguard Group, Inc.

  •  

    46,437

  • +3.58%

  • 2.38

  • State Street Corp

  •  

    27,167

  • -15.73%

  • 1.39

  • Northern Trust Investments, N.A.

  •  

    19,844

  • -12.09%

  • 1.02

  • Renaissance Technologies Corp

  •  

    17,700

  • +14.19%

  • 0.91

Company Profile

Sector

Healthcare

Industry

Medical Instruments & Supplies

Type

Classic Growth

Style

Small Growth

Atrion Corp is incorporated in Delaware. The Company and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products include fluid delivery devices to ophthalmic and cardiovascular product...mores. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and onc...moreology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs advanced pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels, transportation container cases, escape slides, and many other medical and non-medical applications. Its medical products and other components are produced at facilities in Florida, Alabama and Texas. It markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. It sells its products through a sales force which consists of direct sales personnel, independent sales representatives and distributors. The Company currently holds 501 patients. It competes with numerous other companies in the sale of healthcare products. The manufacture and sale of medical products are subject to regulation by numerous United States governmental authorities, mainly the FDA, and corresponding foreign agencies.lessless

Key People

Mr. David A. Battat

CEO/Chairman of the Board, Subsidiary/President/President, Subsidiary

Mr. Emile A. Battat

Chairman of the Board/Chairman of the Board, Subsidiary/Director

Jeffery Strickland

CFO/Chief Accounting Officer/Secretary/Secretary, Subsidiary/Treasurer/Treasurer, Subsidiary/Vice President/Vice President, Subsidiary

Mr. Ronald N. Spaulding

Director

Hugh J. Morgan,Jr

Director

Incorporated

0

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: